TY - JOUR
T1 - Case fatality ratio and mortality rate trends of community-onset Staphylococcus aureus bacteraemia
AU - Tom, S
AU - Galbraith, J C
AU - Valiquette, L
AU - Jacobsson, G
AU - Collignon, P
AU - Schønheyder, H C
AU - Søgaard, M
AU - Kennedy, K J
AU - Knudsen, Inge Jenny Dahl
AU - Andersen, Christian Østergaard
AU - Lyytikäinen, O
AU - Laupland, K B
AU - International Bacteraemia Surveillance Collaborative
N1 - © 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.
PY - 2014
Y1 - 2014
N2 - Lethal outcomes can be expressed as a case fatality ratio (CFR) or as a mortality rate per 100 000 population per year (MR). Population surveillance for community-onset methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) Staphylococcus aureus bacteraemia was conducted in Canada, Australia, Sweden and Denmark to evaluate 30-day CFR and MR trends between 2000 and 2008. The CFR was 20.3% (MSSA 20.2%, MRSA 22.3%) and MR was 3.4 (MSSA 3.1, MRSA 0.3) per 100 000 per year. Although MSSA CFR was stable the MSSA MR increased; MRSA CFR decreased while its MR remained low during the study. Community-onset S. aureus bacteraemia, particularly MSSA, is associated with major disease burden. This study highlights complementary information provided by evaluating both CFR and MR.
AB - Lethal outcomes can be expressed as a case fatality ratio (CFR) or as a mortality rate per 100 000 population per year (MR). Population surveillance for community-onset methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) Staphylococcus aureus bacteraemia was conducted in Canada, Australia, Sweden and Denmark to evaluate 30-day CFR and MR trends between 2000 and 2008. The CFR was 20.3% (MSSA 20.2%, MRSA 22.3%) and MR was 3.4 (MSSA 3.1, MRSA 0.3) per 100 000 per year. Although MSSA CFR was stable the MSSA MR increased; MRSA CFR decreased while its MR remained low during the study. Community-onset S. aureus bacteraemia, particularly MSSA, is associated with major disease burden. This study highlights complementary information provided by evaluating both CFR and MR.
U2 - 10.1111/1469-0691.12564
DO - 10.1111/1469-0691.12564
M3 - Journal article
C2 - 24461038
VL - 20
SP - O630-2
JO - Clinical Microbiology and Infection
JF - Clinical Microbiology and Infection
SN - 1198-743X
IS - 10
ER -